Seaton, Gillian
Smith, Hannah
Brancale, Andrea
Westwell, Andrew D.
Clarkson, Richard
Article History
Received: 27 October 2023
Accepted: 20 December 2023
First Online: 9 January 2024
Declarations
:
: Not applicable.
: Not applicable.
: RC, AW and AB are co-inventors on patents relating to a novel class of BCL3 inhibitors (WO2015/014972 and WO2016/016728). RC, AW and AB are non-executive scientific advisors for TNA Therapeutics Ltd., which has exclusively licenced this BCL3 inhibitor intellectual property.